Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

被引:1
|
作者
Roberts, Matthew J. [1 ,2 ,3 ]
Papa, Nathan [7 ]
Veerman, Hans [10 ,12 ,14 ]
de Bie, Katelijne [12 ,14 ]
Morton, Andrew [3 ]
Franklin, Anthony [1 ,3 ]
Raveenthiran, Sheliyan [3 ]
Yaxley, William J. [3 ]
Donswijk, Maarten L. [11 ]
van der Poel, Henk G. [10 ,12 ,14 ]
Samaratunga, Hemamali [3 ,4 ]
Wong, David [5 ]
Brown, Nicholas [3 ,5 ]
Parkinson, Robert [5 ]
Gianduzzo, Troy [3 ,6 ]
Kua, Boon [3 ,6 ]
Coughlin, Geoffrey D. [3 ,6 ]
Oprea-Lager, Daniela E. [13 ]
Emmett, Louise [8 ,9 ]
van Leeuwen, Pim J. [10 ,14 ]
Yaxley, John W. [1 ,3 ,6 ]
Vis, Andre N. [10 ,12 ]
机构
[1] Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, QLD 4006, Australia
[2] Univ Queensland, UQ Ctr Clin Res, Brisbane, Australia
[3] Univ Queensland, Fac Med, Brisbane, Australia
[4] Aquesta Uropathol, Dept Pathol, Brisbane, QLD, Australia
[5] Wesley Hosp, I Med Radiol, Brisbane, QLD, Australia
[6] Wesley Hosp, Brisbane, QLD, Australia
[7] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, VIC, Australia
[8] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[9] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia
[10] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Urol, Amsterdam, Netherlands
[11] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Nucl Med, Amsterdam, Netherlands
[12] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Urol, Amsterdam, Netherlands
[13] Vrije Univ Amsterdam, Amsterdam Univ, Canc Ctr Amsterdam, Dept Radiol & Nucl Med,Med Ctr, Amsterdam, Netherlands
[14] Prostate Canc Network Netherlands, Amsterdam, Netherlands
关键词
Prostate-specific membrane antigen; PSMA; PET/CT; biochemical failure; radical prostatectomy; Gleason score; QUALITY-OF-LIFE; EXTERNAL VALIDATION; OUTCOMES; RADIOTHERAPY; BIOPSY;
D O I
10.1111/bju.16482
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To construct and externally calibrate a predictive model for early biochemical recurrence (BCR) after radical prostatectomy (RP) incorporating clinical and modern imaging characteristics of the primary tumour. Patients and methods Patients who underwent RP following multiparametric magnetic resonance imaging, prostate biopsy and prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT), from two centres in Australia and the Netherlands. The primary outcome was biochemical recurrence-free survival (BRFS), where BCR was defined as a rising PSA level of >= 0.2 ng/mL or initiation of postoperative treatment per clinician discretion. Proportional hazards models to predict time to event were developed in the Australian sample using relevant pre- and post-surgical parameters and primary tumour maximum standardised uptake value (SUVmax) on diagnostic PSMA-PET/CT. Calibration was assessed in an external dataset from the Netherlands with the same inclusion criteria. Results Data from 846 patients were used to develop the models. Tumour SUVmax was associated with worse predicted 3-year BRFS for both pre- and post-surgical models. SUVmax change from 4 to 16 lessened the predicted 3-year BRFS from 66% to 42% for a patient aged 65 years with typical pre-surgical parameters (PSA level 8 ng/mL, Prostate Imaging-Reporting and Data System score 4/5 and biopsy Gleason score >= 4 + 5). Considering post-surgical variables, a patient with the same age and PSA level but pathological stage pT3a, RP Gleason score >= 4 + 5 and negative margins, SUVmax change from 4 to 16 lessened the predicted 3-year BRFS from 76% to 61%. Calibration on an external sample (n = 464) showed reasonable performance; however, a tendency to overestimate survival in patients with good prognostic factors was observed. Conclusion Tumour SUVmax on diagnostic PSMA-PET/CT has utility additional to commonly recognised variables for prediction of BRFS after RP.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [41] Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy
    Briganti, Alberto
    Karnes, R. Jeffrey
    Joniau, Steven
    Boorjian, Stephen A.
    Cozzarini, Cesare
    Gandaglia, Giorgio
    Hinkelbein, Wolfgang
    Haustermans, Karin
    Tombal, Bertrand
    Shariat, Shahrokh
    Sun, Maxine
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Van Poppel, Hein
    Wiegel, Thomas
    EUROPEAN UROLOGY, 2014, 66 (03) : 479 - 486
  • [42] Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
    Matthew J. Roberts
    Andrew Morton
    Nathan Papa
    Anthony Franklin
    Sheliyan Raveenthiran
    William J. Yaxley
    Geoffrey Coughlin
    Troy Gianduzzo
    Boon Kua
    Louise McEwan
    David Wong
    Brett Delahunt
    Lars Egevad
    Hemamali Samaratunga
    Nicholas Brown
    Robert Parkinson
    Louise Emmett
    John W. Yaxley
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3289 - 3294
  • [43] Prediction of biochemical recurrence after robot-assisted radical prostatectomy: Analysis of 784 Japanese patients
    Hashimoto, Takeshi
    Yoshioka, Kunihiko
    Nagao, Go
    Nakagami, Yoshihiro
    Ohno, Yoshio
    Horiguchi, Yutaka
    Namiki, Kazunori
    Nakashima, Jun
    Tachibana, Masaaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (02) : 188 - 193
  • [44] DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
    Haldrup, Christa
    Mundbjerg, Kamilla
    Vestergaard, Else Marie
    Lamy, Philippe
    Wild, Peter
    Schulz, Wolfgang A.
    Arsov, Christian
    Visakorpi, Tapio
    Borre, Michael
    Hoyer, Soren
    Orntoft, Torben F.
    Sorensen, Karina D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) : 3250 - +
  • [45] Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
    Roberts, Matthew J.
    Morton, Andrew
    Papa, Nathan
    Franklin, Anthony
    Raveenthiran, Sheliyan
    Yaxley, William J.
    Coughlin, Geoffrey
    Gianduzzo, Troy
    Kua, Boon
    McEwan, Louise
    Wong, David
    Delahunt, Brett
    Egevad, Lars
    Samaratunga, Hemamali
    Brown, Nicholas
    Parkinson, Robert
    Emmett, Louise
    Yaxley, John W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3289 - 3294
  • [46] Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy
    Ahlering, Thomas E.
    Huynh, Linda My
    Towe, Maxwell
    See, Kaelyn
    Tran, Joshua
    Osann, Kathryn
    el Khatib, Farouk M.
    Yafi, Faysal A.
    BJU INTERNATIONAL, 2020, 126 (01) : 91 - 96
  • [47] What factors predict biochemical recurrence after radical retropubic prostatectomy?
    O'Malley, P. J.
    Hawizy, A.
    Hurle, R. A.
    Rees, J.
    Hughes, O.
    Kynaston, H.
    BJU INTERNATIONAL, 2006, 97 : 3 - 3
  • [48] Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number
    Simone Albisinni
    Romain Diamand
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 637 - 638
  • [49] Natural history of biochemical recurrence after radical prostatectomy for prostate cancer
    Porter, C.
    Walz, J.
    Gallina, A.
    Jeldres, C.
    Kodama, K.
    Gibbons, R.
    Correa Jr., R.
    Perrotte, P.
    Benard, F.
    Saad, F.
    Karakiewicz, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 181 - 181
  • [50] Does tumor focality predict biochemical recurrence after radical prostatectomy?
    Cheng, L.
    Masterson, T. A.
    Koch, M. O.
    HISTOPATHOLOGY, 2012, 61 : 224 - 224